We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, May 18th:
AcelRxPharmaceuticals, Inc. : This operator of a specialty pharmaceutical companyhas a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 13.3% over the last 60 days.
Acer Therapeutics Inc. (ACER - Free Report) : This developer of therapies for ultra-rare diseaseshas a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 17.2% over the last 60 days.
Arbor Realty Trust, Inc. (ABR - Free Report) : This provider of financial management services has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 14.4% over the last 60 days.
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Image: Bigstock
Top Ranked Momentum Stocks to Buy for May 18th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, May 18th:
AcelRxPharmaceuticals, Inc. : This operator of a specialty pharmaceutical companyhas a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 13.3% over the last 60 days.
AcelRx Pharmaceuticals, Inc. Price and Consensus
AcelRx Pharmaceuticals, Inc. price-consensus-chart | AcelRx Pharmaceuticals, Inc. Quote
AcelRx’s shares gained 25% over the last one month more than S&P 500’s gain of 0.4%. The company possesses a Momentum Score of A.
AcelRx Pharmaceuticals, Inc. Price
AcelRx Pharmaceuticals, Inc. price | AcelRx Pharmaceuticals, Inc. Quote
Acer Therapeutics Inc. (ACER - Free Report) : This developer of therapies for ultra-rare diseaseshas a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 17.2% over the last 60 days.
Opexa Therapeutics, Inc. Price and Consensus
Opexa Therapeutics, Inc. price-consensus-chart | Opexa Therapeutics, Inc. Quote
Acer Therapeutics’ shares gained 4% over the last one month. The company possesses a Momentum Score of A.
Opexa Therapeutics, Inc. Price
Opexa Therapeutics, Inc. price | Opexa Therapeutics, Inc. Quote
Arbor Realty Trust, Inc. (ABR - Free Report) : This provider of financial management services has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 14.4% over the last 60 days.
Arbor Realty Trust Price and Consensus
Arbor Realty Trust price-consensus-chart | Arbor Realty Trust Quote
Arbor Realty’s shares gained 6.6% over the last one month. The company possesses a Momentum Score of A.
Arbor Realty Trust Price
Arbor Realty Trust price | Arbor Realty Trust Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Click here for the 6 trades >>